Biology or methodology?
Authors:
Open Access
- 1 October 2024
- journal article
- Published by Wolters Kluwer Health in Cancer Research, Statistics, and Treatment
- Vol. 7 (4) , 483-484
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Study of frequency and prognostic significance of HER2 overexpression by immunohistochemistry in high-risk endometrial cancer: A retrospective cohort studyCancer Research, Statistics, and Treatment, 2024
- Molecular insights from comprehensive genomic profiling data in advanced metastatic colorectal cancer in South Asian population: A retrospective observational studyCancer Research, Statistics, and Treatment, 2024
- Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II TrialJournal of Clinical Oncology, 2024
- HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable TargetAmerican Society of Clinical Oncology Educational Book, 2022
- Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival AnalysisClinical Cancer Research, 2020